Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways
Maryam Abdulrahman Alahdal, Hadil Alahdal, Najat Binothman, Majidah Aljadani, Nawal Helmi, Maryam A AL-Ghamdi, Alaa Hamed Habib, Misbahuddin Rafeeq · 2026
Read Heptapharmacological activity of Quercetin-3-O-phosphate against lung cancer pathways by Maryam Abdulrahman Alahdal, Hadil Alahdal, Najat Binothman, Majidah Aljadani, Nawal Helmi, Maryam A AL-Ghamdi, Alaa Hamed Habib, Misbahuddin Rafeeq (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0349042.txt.
Description
Alahdal and colleagues screened a modified plant compound against lung cancer targets in a 2026 computer study. Lung cancer kills more people than any other cancer, and tumors often stop responding to single-target drugs. Seven proteins tied to lung tumor growth were chosen as docking targets from a drug database search.
The compound, a phosphate form of a common plant pigment, was tested for fit against all seven targets, a multi-target strategy the authors call heptapharmacology. Strong fits would nominate it for lab testing. Computer docking cannot prove a drug works, but hitting several cancer pathways at once is a rational way to hunt for resistance-proof candidates.
Catalog record
| CREATOR | Maryam Abdulrahman Alahdal, Hadil Alahdal, Najat Binothman, Majidah Aljadani, Nawal Helmi, Maryam A AL-Ghamdi, Alaa Hamed Habib, Misbahuddin Rafeeq |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 109911 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |